Literature DB >> 11718233

Nocturnal enuresis in pediatric sickle cell disease.

L P Barakat1, K Smith-Whitley, S Schulman, D Rosenberg, R Puri, K Ohene-Frempong.   

Abstract

To assess the prevalence of nocturnal enuresis in children and adolescents with sickle cell disease (SCD) and associated factors, structured telephone interviews were conducted with primary caregivers of 217 children and adolescents with SCD aged 5 years or older. Prevalence, perceived causes, interventions undertaken, and emotional impact were assessed. Nocturnal enuresis was significantly higher for males (28.2% of males) than for females (11% of females), p = .002, and compared with cited population prevalence rates, nocturnal enuresis was significantly higher for children with SCD, p < .01. SCD was the most common reason given by primary caregivers for enuresis. Primary caregivers used a wide range of interventions for nocturnal enuresis, but few used empirically supported treatments for enuresis or spoke with their health care team about the enuresis. These data suggest that systematic assessment and intervention for nocturnal enuresis must be implemented in the follow-up care of children and adolescents with SCD.

Entities:  

Mesh:

Year:  2001        PMID: 11718233     DOI: 10.1097/00004703-200110000-00004

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  9 in total

1.  Overactive bladder in adults with sickle cell disease.

Authors:  Uzoma A Anele; Belinda F Morrison; Marvin E Reid; Wendy Madden; Shara Foster; Arthur L Burnett
Journal:  Neurourol Urodyn       Date:  2015-04-14       Impact factor: 2.696

2.  Nocturnal enuresis in sickle cell disease and thalassemia major: associated factors in a clinical sample.

Authors:  Ozalp Ekinci; Tanju Celik; Şule Ünal; Gonul Oktay; Fevziye Toros; Cahit Ozer
Journal:  Int J Hematol       Date:  2013-09-08       Impact factor: 2.490

3.  Nocturnal Enuresis in Sickle Cell: Sociodemographic, Medical, and Quality of Life Factors.

Authors:  Jerlym S Porter; Andrew J Paladino; Kathryn Russell; Rebecca Rupff; Jamilla Griffith; Yujiao Mai; Hui Zhang; Jane S Hankins; Winfred C Wang
Journal:  J Pediatr Psychol       Date:  2022-02-03

4.  Enuresis and Hyperfiltration in Children With Sickle Cell Disease.

Authors:  Rima S Zahr; Juan Ding; Guolian Kang; Winfred C Wang; Jane S Hankins; Kenneth I Ataga; Jeffrey D Lebensburger; Jerlym S Porter
Journal:  J Pediatr Hematol Oncol       Date:  2022-02-18       Impact factor: 1.170

5.  Enuresis is a common and persistent problem among children and young adults with sickle cell anemia.

Authors:  Joshua J Field; Paul F Austin; Ping An; Yan Yan; Michael R DeBaun
Journal:  Urology       Date:  2008-04-02       Impact factor: 2.649

6.  Enuresis associated with sleep disordered breathing in children with sickle cell anemia.

Authors:  Gloria C Lehmann; Teal R Bell; Fenella J Kirkham; Johanna C Gavlak; Tekeda F Ferguson; Robert C Strunk; Paul Austin; Carol L Rosen; Melanie J Marshall; Olu Wilkey; Mark J Rodeghier; John O Warner; Michael R DeBaun
Journal:  J Urol       Date:  2012-08-19       Impact factor: 7.450

7.  Enuresis in children and adolescents with sickle cell anaemia is more frequent and substantially different from the general population.

Authors:  Christopher Imokhuede Esezobor; Patricia Akintan; Uche Nwaogazie; Edna Akinwunmi; Edamisan Temiye; Adebola Akinsulie; Rasheed Gbadegesin
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

8.  Urinary Bladder Dysfunction in Transgenic Sickle Cell Disease Mice.

Authors:  Mário Angelo Claudino; Luiz Osório Silveira Leiria; Fábio Henrique da Silva; Eduardo Costa Alexandre; Andre Renno; Fabiola Zakia Mónica; Gilberto de Nucci; Kleber Yotsumoto Fertrin; Edson Antunes; Fernando Ferreira Costa; Carla Fernanda Franco-Penteado
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

9.  Nocturnal enuresis: prevalence and risk factors among school-aged children with sickle-cell anaemia in a South-east Nigerian city.

Authors:  Chizoma I Eneh; Henrietta U Okafor; Anthony N Ikefuna; Samuel N Uwaezuoke
Journal:  Ital J Pediatr       Date:  2015-09-29       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.